Cite
Frenzel W, Wietek S, Svae TE, et al. Tolerability and safety of Octagam® (IVIG): a post-authorization safety analysis of four non-interventional phase IV trials
. Int J Clin Pharmacol Ther. 2016;54(11):847-855doi: 10.5414/CP202782.
Frenzel, W., Wietek, S., Svae, T. E., Debes, A., & Svorc, D. (2016). Tolerability and safety of Octagam® (IVIG): a post-authorization safety analysis of four non-interventional phase IV trials
. International journal of clinical pharmacology and therapeutics, 54(11), 847-855. https://doi.org/10.5414/CP202782
Frenzel, Wolfgang, et al. "Tolerability and safety of Octagam® (IVIG): a post-authorization safety analysis of four non-interventional phase IV trials
." International journal of clinical pharmacology and therapeutics vol. 54,11 (2016): 847-855. doi: https://doi.org/10.5414/CP202782
Frenzel W, Wietek S, Svae TE, Debes A, Svorc D. Tolerability and safety of Octagam® (IVIG): a post-authorization safety analysis of four non-interventional phase IV trials
. Int J Clin Pharmacol Ther. 2016 Nov;54(11):847-855. doi: 10.5414/CP202782. PMID: 27719744; PMCID: PMC5095453.
Copy
Download .nbib